St. Jude scientists helped lead a comprehensive genomic analysis to uncover the impact of genes on the treatment and outcome of the...

Scientists have created a roadmap of the genetic mutations present in the most common childhood cancer, acute lymphoblastic leukemia...

Blocking a protein chain reaction makes childhood leukemia cells more sensitive to an existing targeted treatment, a new study shows....

Scientists at St. Jude Children’s Research Hospital have revealed how an inherited genetic variant turns on an oncogene, increasing...

St. Jude Children's Research Hospital scientists have shown that addressing racial disparities in acute lymphoblastic leukemia should...

A molecular building block of many animal proteins, the amino acid valine, plays a key role in cancerous growth seen in T cell acute...

Despite major advances in the treatment of acute lymphoblastic leukemia (ALL), adult survivors face long-term health consequences. A ...

According the research, children genetically predisposed to overproduce lymphocytes in relation to other white blood cells are at...

Chemotherapy is standard care for pediatric acute lymphoblastic leukemia (ALL), but new research shows thiopurines can cause mutations ...

Scientists at St. Jude Children’s Research Hospital are working with colleagues in China to develop better therapy for childhood acute...